Biomedical Science Consulting Company, BioSciCon, Inc., is a woman-owned, small business start-up biotechnology company focused on R&D of the proprietary MarkPap® technology. BioSciCon has recently organized a Consortium of business companies to commercialize the MarkPap® technology as new products emerging from the R&D component after translational research from prototypes to products. The other members of this Consortium are MarkPap LLC, MarkPap Pacific, LLC and MarkPap India, LLC.
In 2007, BioSciCon sponsored the creation of The Global Academy for Women's Health, Inc., independent non-profit organization which integrated the multiple prior non-profit activities of BioSciCon's founders continuing their legacy to work for public benefit improving women's health and saving women's lives.
All companies are located in Rockville, MD. BioSciCon headquarters are at Forest Landing Circle, Rockville, MD. Another BioSciCon' facility is at the Johns Hopkins University, Montgomery County Campus, Rockville, MD. MarkPap Pacific LLC and MarkPap India, LLC are located at the Shady Grove Innovation Center in Rockville, MD. The Global Academy for Women's Health, Inc is located at the John's Hopkins University, Montgomery County Campus in Rockville, MD. Please see Contact Us page for details.
The primary mission of BioSciCon, Inc. is to bring the new MarkPap® Technology products to public benefit and save women's lives around the world. The primary function of MarkPap LLC is to commercialize proprietary MarkPap® Technology products after completion of the translational research, and to provide resources for further financing of R&D
Who We Are
Olivera Markovic, M.D., Ph.D
is Founding Director of BioSciCon, Inc. and President of the Global Academy for Women’s Health, Inc. She is also Senior Vice President and Chief Scientific Officer of MarkPap LLC. and MarkPap Pacific, LLC and MarkPap India, LLC.
Nenad Markovic, M.D., Ph.D
is founder and President of BioSciCon, Inc, MarkPap LLC, MarkPap Pacific, LLC and MarkPap India. LLC.
Oleg Panashchenko, Ph.D. is Chief Information Technology Officer-consultant at MarkPap Pacific, LLC. He holds MS degree in Physics and PhD degree in Optical Physics from Moscow Institute of Physics and Technology. Dr. Panashchenko is bringing to the Company his exceptional talents and vast experience in comprehensive software development and information technology experience. He successfully served before in all aspects of software development life-cycle including design, development, implementation and support for Java/J2EE, C++ and mixed language systems for standard, web-based and enterprise-level applications. Prior to joining MarkPap Pacific, Dr. Panashchenko worked for USPTO, Lockheed Martin, Tachyon Networks Planet Exchange, Inc, International Land Systems, Inc, in the US and Tavex and Lucky Net, Kiev, Ukraine.
BioSciCon Cervical Cancer Study Group is a multidisciplinary research group consisting of medical doctors (general practitioners, gynecologists, oncologists and pathologists) from BioSciCon's Clinical and Laboratory Research Sites, and oncologists, biomedical scientists, statisticians, chemists, physicists, computer scientists, and experts in other disciplines affiliated with this program who participate in the BioSciCon's Research Site. Currently active members of the group are highlighted with asterisk. This is a dynamic group of professional teams that are perpetually changing depending on actual programs. Nenad Markovic, MD, PhD* (Research Center), Olivera Markovic, MD, PhD* (Research Center), Lewis Townsend, MD* (Clinical Site), William Smith, MD* (Laboratory Site), James Sundeen, MD (Laboratory Site), David Hankins, PhD (Laboratory Site), Vladan Posarac, MD (Research Center), Mr. Stephen McJonathan* (Microscopy/Imaging), Oleg Panashchenko, PhD* (optical physicist and computer scientist, Research Center), Mr. Derrick Miller (IT/Web), Gary Peck, MD* (Scientific Consultant), Edward Henderson, MD* (Scientific Consultant), S. Kati, PhD (statistician, Research Center), Ing. Marjan Cotic* (IT Consultant), Ing. Cvetan Saljinski* (Imaging/Photography Consultant), Shelly Parr, MD (Clinical Site), Jonathan Cosin, MD (Clinical Site), MIlena Simic (Research Center), Allan Ross, MD (Clinical Site), Venkat Iyer, MD (Clinical Site, India), Pravina Santwani, MD* (Clinical Site, India), Savita Shettar, MD* (Clinical Site, India), Zhenchang Xu (Clinical Site, China), Kalayani Dukipati (Clinical Site, India). Members of this group serve on the Scientific Board per a particular program. Dr. Olivera Markovic coordinates Scientific Board activities.
Business Advisory Team. Business Support Counselors to Small Businesses, Chapter 1, Washington, DC provide continuous business support through Ms. Ann Dobbs and other counselors from the Chapter contributing with their particular expertise. BioSciCon, Inc was SCORE Client of the Year in 2005. MarkPap Pacific LLC is a resident client of the Shady Grove Innovation Center in Rockville MD and is provided with legal and business development support within the Montgomery County Incubators Network. Moawad PC Law firm from Chevy Chase, MD provides legal services. Mr. Duc Duong was an Advisor for China market helping MarkPap Pacific LLC. BioSciCon, Inc. is a Corporate Partner of the Johns Hopkins University, Montgomery County Campus, where it receives business and legal support. Payroll and accountant services are provided by professional contractors. Business professionals constitute The MarkPap LLC Business Advisory Team, which is coordinated by Dr. Nenad Markovic, President and CEO of MarkPap LLC.
MarkPap Technology development has been supported in part by SBIR phases 1 and 2 grants from the National Institutes of Health, Bethesda, MD.We also acknowledge NIH support for business development through the NIH Commercialization Assistance Program (CAP) -- Dawnbreaker, Inc. (2003), Larta Instutue (2007), to foster further commercialization of BioSciCon products. Information about BioSciCon, Inc. and MarkPap® Technology appears on the NIH Web Site, Office of Technology Transfer and SBIR and STTR Success Story for BioSciCon, Inc.